Treatment of patients with cancer using PD-1/PD-L1 antibodies: Adverse effects and management strategies (Review)

In 2020, there were an estimated 19.3 million new cancer cases and close to 10 million cancer deaths worldwide. Cancer remains one of the leading causes of death. In recent years, with the continuous improvement of our understanding of tumor immunotherapy, immunotherapeutics, such as immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Guangshun, Liu, Hanyuan, Shi, Xuesong, Tan, Pengyu, Tang, Weiwei, Chen, Xin, Sun, Guoqiang, Yang, Weijun, Kong, Xiangyi, Zheng, Zhiying, Cao, Hongyong, Shao, Guoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084612/
https://www.ncbi.nlm.nih.gov/pubmed/35485291
http://dx.doi.org/10.3892/ijo.2022.5364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084612/
https://www.ncbi.nlm.nih.gov/pubmed/35485291
http://dx.doi.org/10.3892/ijo.2022.5364

Ejemplares similares